SCHEMBL24935382

SCHEMBL24935382

CC(C)C(=O)COCCCCOc1ccc(C(C)C)cc1Cl

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 2/20 0.45
PPARA Q07869 2/20 0.45
HPGD P15428 3/20 0.43
NLRP1 Q9C000 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
MAPT P10636 1/20 0.41
SMN1; SMN2 Q16637 3/20 0.40
LMNA P02545 2/20 0.40
ALDH1A1 P00352 2/20 0.40
TDP1 Q9NUW8 2/20 0.40
KDM4E B2RXH2 2/20 0.40
PDK2 Q15119 1/20 0.40
TSHR P16473 3/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
GAA P10253 1/20 0.39
THRA P10827 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24936039 0.84 HPGD (0.44) PPARGPPARAHPGDNLRP1NPSR1
SCHEMBL25063933 0.84 MRGPRX4 (0.40) LMNAALDH1A1KDM4ENPC1RAB9A
SCHEMBL24934759 0.82 FFAR1 (0.40) PPARGKDM4ENPC1RAB9AL3MBTL1
SCHEMBL24935185 0.81 KMT2A (0.50) TDP1KDM4EMEN1KMT2ANPC1
SCHEMBL20231597 0.80 PPARG (0.49) PPARGPPARAHPGDNLRP1NPSR1
SCHEMBL20225799 0.79 HPGD (0.48) PPARGPPARAHPGDNLRP1NPSR1
SCHEMBL25063926 0.77 KDM4E (0.42) SMN1; SMN2LMNAALDH1A1KDM4ENPC1
SCHEMBL20225796 0.76 THRA (0.49) PPARGPPARAHPGDMAPTSMN1; SMN2
SCHEMBL10717259 0.76 TDP1 (0.64) MAPTSMN1; SMN2TDP1TSHRMEN1
SCHEMBL24935582 0.76 ACACB (0.38) MAPTSMN1; SMN2MEN1KMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4119546-A1 BIFUNCTIONAL COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF Suzhou Kintor Pharmaceuticals, Inc. (CN) 2023-01-18 EP disclosed